191 related articles for article (PubMed ID: 14693543)
21. Outbreak of imipenem-resistant Acinetobacter baumannii in different wards at a regional hospital related to untrained bedside caregivers.
Wang CH; Li JF; Huang LY; Lin FM; Yang YS; Siu LK; Chang FY; Lin JC
Am J Infect Control; 2017 Oct; 45(10):1086-1090. PubMed ID: 28549878
[TBL] [Abstract][Full Text] [Related]
22. Study of the correlation of imipenem resistance with efflux pumps AdeABC, AdeIJK, AdeDE and AbeM in clinical isolates of Acinetobacter baumannii.
Hou PF; Chen XY; Yan GF; Wang YP; Ying CM
Chemotherapy; 2012; 58(2):152-8. PubMed ID: 22614896
[TBL] [Abstract][Full Text] [Related]
23. PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii.
Bou G; Cerveró G; Domínguez MA; Quereda C; Martínez-Beltrán J
Clin Microbiol Infect; 2000 Dec; 6(12):635-43. PubMed ID: 11284921
[TBL] [Abstract][Full Text] [Related]
24. Investigation and management of an imipenem-resistant oxa-23 Acinetobacter baumannii outbreak in an intensive care unit.
Garlantézec R; Bourigault C; Boles JM; Prat G; Baron R; Tonnelier JM; Cosse M; Lefevre M; Jourdain S; Lelay G; Daniel L; Virmaux M; Le Du I; Tande D; Renault A; Lejeune B
Med Mal Infect; 2011 Aug; 41(8):430-6. PubMed ID: 21640534
[TBL] [Abstract][Full Text] [Related]
25. Risk factors and molecular epidemiology of Acinetobacter baumannii bacteremia in neonates.
Lee HY; Hsu SY; Hsu JF; Chen CL; Wang YH; Chiu CH
J Microbiol Immunol Infect; 2018 Jun; 51(3):367-376. PubMed ID: 28830746
[TBL] [Abstract][Full Text] [Related]
26. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
[TBL] [Abstract][Full Text] [Related]
27. Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study.
Cisneros JM; Rodríguez-Baño J; Fernández-Cuenca F; Ribera A; Vila J; Pascual A; Martínez-Martínez L; Bou G; Pachón J;
Clin Microbiol Infect; 2005 Nov; 11(11):874-9. PubMed ID: 16216101
[TBL] [Abstract][Full Text] [Related]
28. Correlation between antibiotic consumption and carbapenem-resistant Acinetobacter baumannii causing health care-associated infections at a hospital from 2005 to 2010.
Tan CK; Tang HJ; Lai CC; Chen YY; Chang PC; Liu WL
J Microbiol Immunol Infect; 2015 Oct; 48(5):540-4. PubMed ID: 24685280
[TBL] [Abstract][Full Text] [Related]
29. A systematic review and meta-analysis for risk factor profiles in patients with resistant Acinetobacter baumannii infection relative to control patients.
Deshwal PR; Fathima R; Aggarwal M; Reddy NS; Tiwari P
Int J Risk Saf Med; 2023; 34(4):337-355. PubMed ID: 37154184
[TBL] [Abstract][Full Text] [Related]
30. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings.
Garnacho-Montero J; Ortiz-Leyba C; Fernández-Hinojosa E; Aldabó-Pallás T; Cayuela A; Marquez-Vácaro JA; Garcia-Curiel A; Jiménez-Jiménez FJ
Intensive Care Med; 2005 May; 31(5):649-55. PubMed ID: 15785929
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of drug resistance of Acinetobacter baumannii and its related factors in ICU].
Ma MY; Xu J; Yu N; Huang GM
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Nov; 25(11):686-9. PubMed ID: 24225215
[TBL] [Abstract][Full Text] [Related]
32. A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii.
Huang H; Chen B; Liu G; Ran J; Lian X; Huang X; Wang N; Huang Z
BMC Infect Dis; 2018 Jan; 18(1):11. PubMed ID: 29304746
[TBL] [Abstract][Full Text] [Related]
33. Infection with Acinetobacter baumannii in an intensive care unit in the Western part of Romania.
Lăzureanu V; Poroșnicu M; Gândac C; Moisil T; Bădițoiu L; Laza R; Musta V; Crișan A; Marinescu AR
BMC Infect Dis; 2016 Mar; 16 Suppl 1(Suppl 1):95. PubMed ID: 27169538
[TBL] [Abstract][Full Text] [Related]
34. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Turk Dagi H; Kus H; Arslan U; Tuncer I
Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
[TBL] [Abstract][Full Text] [Related]
35. Carbapenem resistance in Acinetobacter baumannii: where is it heading?
Deveci Ö; Dal T; Tekin R; Bozkurt F; Tekin A; Dayan S
Infez Med; 2013 Sep; 21(3):211-5. PubMed ID: 24008854
[TBL] [Abstract][Full Text] [Related]
36. Colonization pressure and risk factors for acquisition of imipenem-resistant Acinetobacter baumannii in a medical surgical intensive care unit in Brazil.
Castelo Branco Fortaleza CM; Moreira de Freitas F; da Paz Lauterbach G
Am J Infect Control; 2013 Mar; 41(3):263-5. PubMed ID: 22878125
[TBL] [Abstract][Full Text] [Related]
37. Identification of an atypical integron carrying an IS26-disrupted aadA1 gene cassette in Acinetobacter baumannii.
Han HL; Jang SJ; Park G; Kook JK; Shin JH; Shin SH; Kim DM; Cheon JS; Moon DS; Park YJ
Int J Antimicrob Agents; 2008 Aug; 32(2):165-9. PubMed ID: 18565738
[TBL] [Abstract][Full Text] [Related]
38. A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.
Boral B; Unaldi Ö; Ergin A; Durmaz R; Eser ÖK;
Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):19. PubMed ID: 31266519
[TBL] [Abstract][Full Text] [Related]
39. [Activity of imipenem and meropenem against strains of Acinetobacter baumannii isolated from various Chilean hospitals].
Bello H; Domínguez M; Sepúlveda M; Cerda F; González G; Mella S; Zemelman R
Rev Esp Quimioter; 2000 Dec; 13(4):405-7. PubMed ID: 11498708
[TBL] [Abstract][Full Text] [Related]
40. Nosocomial Acinetobacter baumannii infection in children in adult versus pediatric intensive care units.
Kim B; Kim K; Yoon JS
Pediatr Int; 2020 Apr; 62(4):451-458. PubMed ID: 31887243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
